High Court to determine if isolated genetic material is patentable subject matter in Australia
The Australian High Court has allowed Yvonne D’Arcy’s special leave application from the Full Federal Court decision in D’Arcy v Myriad Genetics Inc [2014] FCAFC 115. As a result, the patent claims directed to the gene BRCA1 (which has been found to exhibit particular mutations in women with an enhanced risk of developing breast and ovarian cancer) will be considered by the High Court sometime this year. Read More …